市場調查報告書

血小板凝集設備的全球市場 - 成長,趨勢,預測(2018年∼2023年)

Platelet Aggregation Devices Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 708603
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
Back to Top
血小板凝集設備的全球市場 - 成長,趨勢,預測(2018年∼2023年) Platelet Aggregation Devices Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日內容資訊: 英文 120 Pages
簡介

全球血小板凝集設備市場在2018年到2023年間,預測將以約19%的年複合成長率擴大。

本報告提供血小板凝集設備的全球市場調查,提供市場概要,各類型,用途,終端用戶,各地區的市場趨勢,市場規模的變化與預測,市場促進·阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要

  • 市場方案
  • 波特的五力分析
    • 供應商談判力
    • 買方議價能力
    • 產業內的競爭
    • 替代品的威脅
    • 新加入廠商的威脅

第6章 市場動態

  • 成長要素
  • 阻礙因素
  • 市場機會
  • 課題

第7章 市場區隔

  • 各產品
    • 系統
    • 試劑
    • 消耗品·配件
  • 各用途
    • 臨床
    • 研究
  • 各終端用戶
    • 醫院
    • 診斷實驗室
    • 研究機關·學術機構
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第8章 企業簡介

  • Accriva Diagnostics Holdings Inc.
  • Aggredyne Inc.
  • Bio/Data Corporation
  • F. Hoffman-La Roche Ltd.
  • Haemonetics Corporation
  • Helena Laboratories Corporation
  • Sentinel Ch. SPA
  • Siemens AG
  • Sysmex Corporation
  • TEM Group

第9章 市場未來展望

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 64152

Traditional aggregometer work on the principle of light transmission. The traditional aggregometer performs light transmission aggregometry (LTA) which was once considered as the gold standard for platelet function testing and is still used for the identification and diagnosis of platelet function defects. Traditional LTA remains the most useful technique for diagnosing a wide variety of platelet defects. Additionally, LTA requires a large sample volume, is time-consuming, and there are many pre-analytical and analytical variables that affect the LTA results. These shortcomings in traditional aggregometry spurred the development and advancement of aggregometry techniques which is widely being adopted in the current market. The platelet function analyzers (PFA) are the result of such developments. The platelet function tests performed through a PFA are automated, rapid and mimics several characteristics of physiologic platelet function, because it is a high shear system. Hence, the advancements in aggregometry are improving the adoption rate of these devices and in turn helping in the market growth.

Key Market Trends

Hospital Segment is Expected to Dominate the Market in the Forecast Years

Based on end user, the market is segmented into hospitals, diagnostic laboratories, and others. The factors attributing to the dominance of this segment are a larger patient pool, availability of skilled technicians, and enhanced healthcare infrastructure across the globe. The rise in patient pool, due to substantial growth in the population suffering from diseases, such as bleeding disorders, cardiovascular diseases, and arthritis, is expected to enhance revenue generations of the hospitals. Furthermore, several benefits offered by hospitals in conducting platelet aggregation testing procedures, the high accessibility, and affordability of hospitals are expected to attract a large patient population. Hence, these factors are expected to fuel market growth in the forecast period.

North America holds the Largest Share in the Platelet Aggregation Devices Market

The North America region holds the largest market share due to strong presence of device manufacturers, large patient population for target diseases, growing number of surgical procedures, and rising awareness among healthcare professionals regarding the benefits offered by platelet aggregation testing in disease diagnosis. Additionally, factors like large number of patients undergoing cardiovascular surgeries, and increasing prevalence of orthopedic, urological, and bleeding disorders is expected to sustain the market leader status of North America supported by high growth rate.

Competitive Landscape

The market studied is moderately competitive and there are several international companies that are operating in this market. The global players into the platelet aggregation devices market are Aggredyne Inc., Bio/Data Corporation, Chrono-Log Corporation, F. Hoffmann-La Roche Ltd, Haemonetics Corporation, Helena Laboratories Corporation, Sentinel Ch. S.P.A., Siemens AG and WerfenLife, S.A.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Target Diseases
    • 4.2.2 Increasing Geriatric Population
    • 4.2.3 Technological Advancements in Platelet Aggregometers
  • 4.3 Market Restraints
    • 4.3.1 Dearth of Skilled Professionals
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Systems
    • 5.1.2 Reagents
    • 5.1.3 Consumables and Accessories
  • 5.2 By Application
    • 5.2.1 Clinical Applications
    • 5.2.2 Research Applications
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Diagnostic Laboratories
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Aggredyne, Inc.
    • 6.1.2 Bio/Data Corporation
    • 6.1.3 Chrono-Log Corporation
    • 6.1.4 F. Hoffmann-La Roche Ltd
    • 6.1.5 Haemonetics Corporation
    • 6.1.6 Helena Laboratories Corporation
    • 6.1.7 Sentinel Ch. S.P.A.
    • 6.1.8 Siemens AG
    • 6.1.9 WerfenLife, S.A.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top